A Phase I, Dose-Expansion Cohort Study On The Safety Of A Cannabidiol For Biochemical Recurrence In Prostate Cancer Patients.
JOURNAL OF CLINICAL ONCOLOGY(2021)
Abstract
TPS263Background: Cannabinoids, widely used in pain control, as an appetite stimulant, and anti-emetic in cancer patients, may play role as an anti-carcinogenic agent. A preclinical study demonstra...
MoreTranslated text
Key words
cannabidiol,prostate cancer,prostate cancer patients,biochemical recurrence,dose-expansion
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined